• Sorry! To unlock all site features, we'll need to collect some information from you.
  • Unit 7.6: Heparin-Induced Thrombocytopenia

    Neal Kleiman, MD — The Methodist Hospital, Baylor College of Medicine and / George D. Dangas, MD, PhD — Columbia University Medical

    Duration:1 hour

    Faculty Disclosure

    Dr. Kleinman:

    • Grant and/or Research Support: Millennium Therapeutics; The Medicines Company
    • Consultant: Sanofi-Aventis

    Dr. Dangas:
    Nothing to Disclose

    Learning Objectives

    • Name the clinical characteristics of HIT
    • List the different types and uses of direct thrombin inhibitors
    • Provide an overview of clinical trials of heparin-induced thrombocytopenia
    • List the various types of coronary interventions in patients with HIT